E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Add to balance / Manage account  User:  Log out
Prospect News home > News index > List of issuers E > Headlines for Eiger BioPharmaceuticals, Inc. > News item
Published on 8/17/2016 in the Prospect News PIPE Daily.

Eiger BioPharmaceuticals will conduct public offering of common stock

Offering will be conducted by Jefferies, Oppenheimer, Wedbush PacGrow

By Devika Patel

Knoxville, Tenn., Aug. 17 – Eiger BioPharmaceuticals, Inc. said it plans a public sale of stock with a 30-day, 15% greenshoe.

Jefferies LLC is the bookrunner. Oppenheimer & Co. Inc. and Wedbush PacGrow are the co-managers

Proceeds will be used for clinical development, working capital and other general corporate purposes.

The biopharmaceutical company is based in Palo Alto, Calif.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.